Latest News about mRNA
Recent news which mentions mRNA
Is It Time to Buy September's Worst-Performing S&P 500 Stocks?
October 02, 2024
From Motley Fool
The Covid Era Tech Promises To Reinvent Cancer Treatment
October 01, 2024
From Benzinga
3 Surprisingly Underrated Stocks to Buy Right Now
September 28, 2024
From Motley Fool
Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today
September 24, 2024
From Benzinga
Top 3 Health Care Stocks That May Explode This Month
September 23, 2024
From Benzinga
2 Beaten-Down Stocks to Buy and Hold for a Decade
September 23, 2024
From Motley Fool
Pfizer Advances On Its Cancer Journey
September 20, 2024
From Benzinga
Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks
September 19, 2024
From Motley Fool
Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks
September 19, 2024
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 18, 2024
From Benzinga
Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse
September 18, 2024
From Benzinga
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
September 18, 2024
From Motley Fool
S&P 500 Briefly Hits Record High Just Ahead Of Fed Rate Cut, Extends 7-Day Winning Streak: Tuesday's Top 5 Gainers
September 17, 2024
From Benzinga
Small Caps, Bitcoin Rally As Traders Await Fed Rate Cut; Treasury Yields, US Dollar Tick Up On Strong Retail Sales: What's Driving Markets Tuesday?
September 17, 2024
From Benzinga
What's Going On With Moderna Shares Tuesday?
September 17, 2024
From Benzinga
DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
September 16, 2024
From Benzinga
Moderna, Tyson Foods And Adobe Are Among Top 10 Large Cap Stock Losers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
September 15, 2024
From Benzinga
Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path?
September 15, 2024
Tickers
MRNA
From Motley Fool
Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More
September 14, 2024
From Motley Fool
After Moderna's Shocking News, Is the Stock a Buy or a Sell?
September 14, 2024
Tickers
MRNA
From Motley Fool
Moderna Faces Analyst Downgrades Amid Revised R&D Restructured Strategy and Delayed Profitability Target
September 13, 2024
From Benzinga
Here's How Much You Would Have Made Owning Moderna Stock In The Last 5 Years
September 13, 2024
From Benzinga
Oracle To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Friday
September 13, 2024
From Benzinga
Tradepulse Power Inflow Alert: Moderna Inc. Rises 8.9% On The Trading Day
September 13, 2024
Tickers
MRNA
From Benzinga
Should You Buy Novavax Stock After This Regulatory Win?
September 13, 2024
From Motley Fool
A Bull Market Is Here: 2 High-Potential Stocks Down More Than 50% to Buy Right Now
September 13, 2024
From Motley Fool
From Benzinga
Why Are Novavax Shares Trading Lower Today?
September 12, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
